Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

7.09
Delayed Data
As of Apr 25
 +0.25 / +3.65%
Today’s Change
4.45
Today|||52-Week Range
8.72
+32.52%
Year-to-Date
No recent news for ZIOPHARM Oncology Inc.

Today’s Trading

Previous close6.84
Today’s open6.86
Day’s range6.86 - 7.27
Volume1,391,657
Average volume (3 months)1,440,642
Market cap$905.5M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)+56.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+58.38%
P/E ratioNM
Price/Sales101.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc+0.90+3.70%
SGYPSynergy Pharmaceutic...+0.10+2.43%
FWPForward Pharma A/S-0.04-0.20%
ESPREsperion Therapeutic...-0.49-1.31%
Data as of 4:01pm ET, 04/25/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$6.9M
Annual profit (last year)-$165.3M
Net profit margin-2,409.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs